Contact
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
The Pharmacies market in G20 is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the expansion of the Pharmacies market in G20.
Customer preferences: Customers in the G20 countries are increasingly prioritizing convenience and accessibility when it comes to healthcare services. Pharmacies offer a one-stop solution for various healthcare needs, including prescription medications, over-the-counter drugs, and health and wellness products. With the busy lifestyles of consumers in G20 countries, the convenience of being able to access these products and services in one location is highly appealing. Additionally, customers are also seeking personalized and expert advice from pharmacists, who play a crucial role in providing healthcare guidance and recommendations.
Trends in the market: One of the key trends in the Pharmacies market in G20 is the increasing focus on e-commerce and online pharmacy platforms. With the rise of digitalization and the growing popularity of online shopping, customers are now able to purchase medications and healthcare products online, with the added convenience of doorstep delivery. This trend is particularly prominent in countries with high internet penetration rates and advanced logistics infrastructure. Furthermore, the COVID-19 pandemic has accelerated the adoption of online pharmacy services, as customers seek to minimize physical contact and avoid crowded spaces.
Local special circumstances: Each country within the G20 has its own unique set of circumstances that impact the Pharmacies market. For example, in countries with aging populations, there is a higher demand for medications and healthcare products, leading to a larger market size. Additionally, countries with universal healthcare systems may have different regulations and reimbursement policies that affect the operations and profitability of pharmacies. Cultural factors and traditional medicine practices also play a role in shaping customer preferences and the types of products and services offered by pharmacies.
Underlying macroeconomic factors: The overall economic growth and development of the G20 countries have a direct impact on the Pharmacies market. As disposable incomes rise, consumers have more purchasing power and are willing to spend on healthcare products and services. Furthermore, advancements in healthcare technologies and research contribute to the development of new and innovative medications, which in turn drive the growth of the Pharmacies market. Government policies and regulations, such as price controls and intellectual property rights, also influence the market dynamics and competitiveness of pharmacies in the G20 countries. In conclusion, the Pharmacies market in G20 is experiencing growth and development driven by customer preferences for convenience and accessibility, trends in e-commerce and online pharmacy platforms, local special circumstances, and underlying macroeconomic factors. As the healthcare landscape continues to evolve, pharmacies will play a crucial role in meeting the diverse healthcare needs of customers in the G20 countries.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)